A seminal, annual meeting updating advisers on next season’s influenza vaccines was abruptly canceled by the Food and Drug Administration. The FDA’s Vaccines and Related Biological Products Advisory Committee was slated to meet on March 13,

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, an adviser on the panel and multiple officials confirm to CBS News, potentially upending the process to start manufacturing next winter's flu shots.

A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters, the second such disruption to a federal vaccine advisory panel since Robert F.